Literature DB >> 1596568

In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells.

M Eder1, O G Ottmann, T E Hansen-Hagge, C R Bartram, S Falk, S Gillis, D Hoelzer, A Ganser.   

Abstract

We investigated the effects of interleukin-3 (IL-3), IL-7, IL-1, and IL-6, of irradiated bone marrow-derived fibroblasts (Fb) and of in vitro matured peripheral blood macrophages (M phi), on the survival, proliferation, and maturation of purified blasts from nine common acute lymphoblastic leukemias (cALLs) in 7-day suspension culture. Exposure to IL-3, IL-7, IL-1, and IL-6 resulted in a mean 2.8-, 1.5-, 1.4-, and 1.6-fold stimulation of 3H-thymidine (3H-TdR) incorporation, respectively. Cocultures of cALL blasts with irradiated M phi, either allowing direct cell-cell contact or preventing it by membrane filters, or with irradiated Fb, resulted in a mean 31.7-, 4.1-, and 11.2-fold increase of 3H-TdR incorporation, respectively. Southern blot analysis of immunoglobulin and T-cell receptor (TCR) gene rearrangements before and after culture indicated exclusive proliferation of the leukemic clone in three of eight samples, whereas additional generation of nonleukemic cells was found in five samples. Polyclonal growth pattern corresponded to the detection of heterogeneous cell populations using FACS analysis. Survival of cALL blasts as defined by the detection of cells coexpressing both CD10 and CD19 after culture was supported by accessory cells in five of eight samples. No evidence of induced lymphoid maturation was found under any culture condition. Our data demonstrate supportive effects of stromal cells on cALL growth, which cannot be replaced by IL-3 or IL-7.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596568

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  A primitive cell origin for B-cell precursor ALL?

Authors:  C V Cox; A Blair
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

2.  Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease.

Authors:  H D Foss; M Hummel; S Gottstein; K Ziemann; B Falini; H Herbst; H Stein
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

Review 3.  Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia.

Authors:  Noa Tal; Chen Shochat; Ifat Geron; Dani Bercovich; Shai Izraeli
Journal:  Cell Mol Life Sci       Date:  2013-04-27       Impact factor: 9.261

4.  Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia.

Authors:  D Pal; H J Blair; A Elder; K Dormon; K J Rennie; D J L Coleman; J Weiland; K S Rankin; A Filby; O Heidenreich; J Vormoor
Journal:  Leukemia       Date:  2016-05-25       Impact factor: 11.528

5.  IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor.

Authors:  Ilaria Roato; Giacomina Brunetti; Eva Gorassini; Maria Grano; Silvia Colucci; Lisa Bonello; Lucio Buffoni; Roberto Manfredi; Enrico Ruffini; Davide Ottaviani; Libero Ciuffreda; Antonio Mussa; Riccardo Ferracini
Journal:  PLoS One       Date:  2006-12-27       Impact factor: 3.240

Review 6.  Interleukin-7 and interleukin-15 for cancer.

Authors:  Paul Zarogoulidis; Sofia Lampaki; Lonny Yarmus; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Katsikogiannis; Wolfgang Hohenforst-Schmidt; Qiang Li; Haidong Huang; Antonios Sakkas; John Organtzis; Leonidas Sakkas; Ioannis Mpoukovinas; Kosmas Tsakiridis; George Lazaridis; Konstantinos Syrigos; Konstantinos Zarogoulidis
Journal:  J Cancer       Date:  2014-10-22       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.